Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Salloway

Showing results (11-20 of 195) with videos related to

Pageof 20
Sort By:
Neurology|July 31, 2012
Imaging markers of incipient dementia: the white matter mattersOwen T Carmichael, Stephen Salloway
International Psychogeriatrics|June 29, 2007
Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCIStephen Salloway, Stephen Correia, Sharon Richardson
JAMA|June 19, 2019
Putting the New Alzheimer Disease Amyloid, Tau, Neurodegeneration (AT[N]) Diagnostic System to the TestDavid Wolk, Stephen Salloway, Brad Dickerson
The American Journal of Medicine|April 29, 2017
Alzheimer's Disease in Primary Care: The Significance of Early Detection, Diagnosis, and InterventionLawrence Herman, Alireza Atri, Stephen Salloway
JAMA|July 28, 2024
Are Blood Tests for Alzheimer Disease Ready for Prime Time?Stephen Salloway, Christopher Rowe, Jeffrey M Burns
Neurology|December 21, 2018
Are lobar microbleeds of diagnostic value in the community?Ashkan Shoamanesh, Stephen Salloway, Carlos S Kase
The Journal of Prevention of Alzheimer'S Disease|June 14, 2025
Editorial comment to: Breaking barriers: Delivering therapeutics to the brain in Alzheimer's diseaseBart De Strooper, Philip Scheltens, Stephen Salloway
The New England Journal of Medicine|April 12, 2014
Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's diseaseStephen Salloway, Reisa Sperling, H Robert Brashear
Medicine and Health, Rhode Island|August 17, 2002
Dementia with Lewy bodies: a diagnostic and treatment challengeStephen Salloway, Stephen Correia, Jason Peck, et al.
The Journal of Clinical Psychiatry|June 13, 2012
A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's diseaseLaura L Frakey, Stephen Salloway, Melissa Buelow, et al.
Pageof 20

Showing results (11-20 of 195) with videos related to

Sort By:
Pageof 20
Neurology|July 31, 2012
Imaging markers of incipient dementia: the white matter mattersOwen T Carmichael, Stephen Salloway
International Psychogeriatrics|June 29, 2007
Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCIStephen Salloway, Stephen Correia, Sharon Richardson
JAMA|June 19, 2019
Putting the New Alzheimer Disease Amyloid, Tau, Neurodegeneration (AT[N]) Diagnostic System to the TestDavid Wolk, Stephen Salloway, Brad Dickerson
The American Journal of Medicine|April 29, 2017
Alzheimer's Disease in Primary Care: The Significance of Early Detection, Diagnosis, and InterventionLawrence Herman, Alireza Atri, Stephen Salloway
JAMA|July 28, 2024
Are Blood Tests for Alzheimer Disease Ready for Prime Time?Stephen Salloway, Christopher Rowe, Jeffrey M Burns
Neurology|December 21, 2018
Are lobar microbleeds of diagnostic value in the community?Ashkan Shoamanesh, Stephen Salloway, Carlos S Kase
The Journal of Prevention of Alzheimer'S Disease|June 14, 2025
Editorial comment to: Breaking barriers: Delivering therapeutics to the brain in Alzheimer's diseaseBart De Strooper, Philip Scheltens, Stephen Salloway
The New England Journal of Medicine|April 12, 2014
Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's diseaseStephen Salloway, Reisa Sperling, H Robert Brashear
Medicine and Health, Rhode Island|August 17, 2002
Dementia with Lewy bodies: a diagnostic and treatment challengeStephen Salloway, Stephen Correia, Jason Peck, et al.
The Journal of Clinical Psychiatry|June 13, 2012
A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's diseaseLaura L Frakey, Stephen Salloway, Melissa Buelow, et al.
Pageof 20